Loading…
Based on limited metadata with no full letter text available, bB BioChem Laboratories Inc. received an FDA Warning Letter on July 3, 2018, regarding products classified as "Other" under FDA jurisdiction. Without access to the subject line or detailed violation information, the specific nature of the regulatory concerns cannot be determined from the available metadata. The issuing office is also not identified in the provided information, limiting visibility into which FDA division or center initiated the enforcement action.